These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 19687579

  • 1. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
    Takei K, Araki N, Ohkubo T, Tamura N, Yamamoto T, Furuya D, Yanagisawa CT, Shimazu K.
    Intern Med; 2009; 48(16):1357-61. PubMed ID: 19687579
    [Abstract] [Full Text] [Related]

  • 2. Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.
    Soeki T, Kitani M, Kusunose K, Yagi S, Taketani Y, Koshiba K, Wakatsuki T, Orino S, Kawano K, Sata M.
    Hypertens Res; 2012 Nov; 35(11):1058-62. PubMed ID: 22763473
    [Abstract] [Full Text] [Related]

  • 3. Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.
    Shimizu H, Nakagami H, Yasumasa N, Mariana OK, Kyutoku M, Koriyama H, Nakagami F, Shimamura M, Rakugi H, Morishita R.
    Hypertens Res; 2012 Jan; 35(1):77-81. PubMed ID: 21881574
    [Abstract] [Full Text] [Related]

  • 4. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
    Ogura C, Ono K, Miyamoto S, Ikai A, Mitani S, Sugimoto N, Tanaka S, Fujita M.
    Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
    [Abstract] [Full Text] [Related]

  • 5. Comparison between L-type and N/L-type calcium channel blockers in the regulation of home blood-pressure variability in elderly hypertensive patients.
    Nozato S, Yamamoto K, Nozato Y, Takeda M, Hongyo K, Takeya M, Akasaka H, Takami Y, Takeya Y, Sugimoto K, Ito N, Rakugi H.
    Hypertens Res; 2018 Apr; 41(4):290-298. PubMed ID: 29449705
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
    Aritomi S, Harada E, Sugino K, Nishimura M, Nakamura T, Takahara A.
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553
    [Abstract] [Full Text] [Related]

  • 7. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T, Shigematsu M.
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
    Ando K, Ueshima K, Tanaka S, Kosugi S, Sato T, Matsuoka H, Nakao K, Fujita T.
    Int J Med Sci; 2013 Nov; 10(9):1209-16. PubMed ID: 23935398
    [Abstract] [Full Text] [Related]

  • 9. L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease.
    Abe M, Maruyama N, Suzuki H, Inoshita A, Yoshida Y, Okada K, Soma M.
    Heart Vessels; 2013 Jul; 28(4):480-9. PubMed ID: 22914905
    [Abstract] [Full Text] [Related]

  • 10. Comparison of effects of L/N-type and L-type calcium channel blockers on post-infarct cardiac remodelling in spontaneously hypertensive rats.
    Naseratun N, Kobara M, Watanabe Y, Toba H, Nakata T.
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1545-1553. PubMed ID: 32323339
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
    Hoshide S, Kario K, Ishikawa J, Eguchi K, Shimada K.
    Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
    [Abstract] [Full Text] [Related]

  • 12. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T.
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [Abstract] [Full Text] [Related]

  • 13. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
    Sakata K, Shirotani M, Yoshida H, Nawada R, Obayashi K, Togi K, Miho N.
    Hypertension; 1999 Jun; 33(6):1447-52. PubMed ID: 10373231
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients.
    Masaki M, Mano T, Eguchi A, Fujiwara S, Sugahara M, Hirotani S, Tsujino T, Komamura K, Koshiba M, Masuyama T.
    Heart Vessels; 2016 Nov; 31(11):1826-1833. PubMed ID: 26825736
    [Abstract] [Full Text] [Related]

  • 15. L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
    Kanaoka T, Tamura K, Wakui H, Ohsawa M, Azushima K, Uneda K, Kobayashi R, Fujikawa T, Tsurumi-Ikeya Y, Maeda A, Yanagi M, Toya Y, Umemura S.
    Int J Mol Sci; 2013 Aug 16; 14(8):16866-81. PubMed ID: 23959116
    [Abstract] [Full Text] [Related]

  • 16. Effect of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulsed Doppler echocardiography and pulsed tissue Doppler imaging.
    Onose Y, Oki T, Yamada H, Manabe K, Kageji Y, Matsuoka M, Yamamoto T, Tabata T, Wakatsuki T, Ito S.
    Jpn Circ J; 2001 Apr 16; 65(4):305-9. PubMed ID: 11316128
    [Abstract] [Full Text] [Related]

  • 17. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S, Yano Y, Maki K, Iwasaka T.
    J Hypertens; 2007 Oct 16; 25(10):2178-83. PubMed ID: 17885563
    [Abstract] [Full Text] [Related]

  • 18. Effects of the L/N-Type Ca2+ Channel Blocker Cilnidipine on the Cardiac Histological Remodelling and Inducibility of Atrial Fibrillation in High-Salt-Fed Rats.
    Harada E, Sugino K, Aimoto M, Takahara A.
    Biol Pharm Bull; 2021 May 01; 44(5):707-713. PubMed ID: 33642455
    [Abstract] [Full Text] [Related]

  • 19. The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet.
    Aritomi S, Koganei H, Wagatsuma H, Mitsui A, Ogawa T, Nitta K, Konda T.
    Heart Vessels; 2010 Nov 01; 25(6):549-55. PubMed ID: 20922532
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.